Anti-osteoporotic effects of Boswellia serrata gum resin extract in vitro and in vivo
- PMID: 38854466
- PMCID: PMC11156763
- DOI: 10.4162/nrp.2024.18.3.309
Anti-osteoporotic effects of Boswellia serrata gum resin extract in vitro and in vivo
Abstract
Background/objectives: This study evaluated the beneficial effects of an ethanol extract of Boswellia serrata gum resin (FJH-UBS) in osteoporosis.
Materials/methods: MC3T3-E1 osteoblastic cells and RAW 264.7 osteoclastic cells were treated with FJH-UBS. The alkaline phosphatase (ALP) activity, mineralization, collagen synthesis, osteocalcin content, and Runt-related transcription factor 2 (RUNX2) and Osterix expression were measured in MC3T3-E1 cells. The actin ring structures, tartrate-resistant acid phosphatase (TRAP) activity, and the nuclear factor of activator T-cells, cytoplasm 1 (NFATc1) expression were evaluated in RAW 264.7 cells. Ovariectomized ICR mice were orally administered FJH-UBS for eight weeks. The bone mineral density (BMD) and the serum levels of osteocalcin, procollagen 1 N-terminal propeptide (P1NP), osteoprotegerin, and TRAP 5b were analyzed.
Results: FJH-UBS increased the ALP activity, collagen, osteocalcin, mineralization, and RUNX2 and osterix expression in MC3T3-E1 osteoblastic cells, whereas it decreased the TRAP activity, actin ring structures, and NFATc1 expression in RAW 264.7 osteoclastic cells. In ovariectomy-induced osteoporosis mice, FJH-UBS positively restored all of the changes in the bone metabolism biomarkers (BMD, osteocalcin, P1NP, osteoprotegerin, and TRAP 5b) caused by the ovariectomy.
Conclusion: FJH-UBS has anti-osteoporotic activity by promoting osteoblast activity and inhibiting osteoclast activity in vitro and in vivo, suggesting that FJH-UBS is a potential functional food ingredient for osteoporosis.
Keywords: Boswellia; osteoblasts; osteoclast; osteoporosis; ovariectomy.
©2024 The Korean Nutrition Society and the Korean Society of Community Nutrition.
Conflict of interest statement
Conflict of Interest: The authors declare no potential conflicts of interest.
Figures






Similar articles
-
Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation.BMC Complement Altern Med. 2014 Jun 6;14:184. doi: 10.1186/1472-6882-14-184. BMC Complement Altern Med. 2014. PMID: 24903150 Free PMC article.
-
(-)-Epiafzelechin Protects against Ovariectomy-induced Bone Loss in Adult Mice and Modulate Osteoblastic and Osteoclastic Functions In Vitro.Nutrients. 2017 May 22;9(5):530. doi: 10.3390/nu9050530. Nutrients. 2017. PMID: 28531166 Free PMC article.
-
Hijikia fusiforme protects against ovariectomy-induced bone loss in rats.J Med Food. 2012 Apr;15(4):384-90. doi: 10.1089/jmf.2011.1827. Epub 2012 Feb 8. J Med Food. 2012. PMID: 22316296
-
Anti-osteoporosis effects of osteoking via reducing reactive oxygen species.J Ethnopharmacol. 2019 Nov 15;244:112045. doi: 10.1016/j.jep.2019.112045. Epub 2019 Jun 29. J Ethnopharmacol. 2019. PMID: 31260757
-
The Role of Rosavin in the Pathophysiology of Bone Metabolism.Int J Mol Sci. 2024 Feb 9;25(4):2117. doi: 10.3390/ijms25042117. Int J Mol Sci. 2024. PMID: 38396794 Free PMC article. Review.
References
-
- Langdahl BL. Overview of treatment approaches to osteoporosis. Br J Pharmacol. 2021;178:1891–1906. - PubMed
-
- He JB, Chen MH, Lin DK. New insights into the tonifying kidney-yin herbs and formulas for the treatment of osteoporosis. Arch Osteoporos. 2017;12:14. - PubMed
-
- Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, et al. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci. 2007;1117:209–257. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous